Effect of metabolic syndrome and thyroid hormone on efficacy of desvenlafaxine 50 and 100 mg/d in major depressive disorder

医学 重性抑郁障碍 内科学 代谢综合征 甲状腺 内分泌学 激素 萧条(经济学) 精神科 肥胖 宏观经济学 经济 扁桃形结构
作者
Roger S. McIntyre,Rana S. Fayyad,Joan A. Mackell,Matthieu Boucher
出处
期刊:Current Medical Research and Opinion [Taylor & Francis]
卷期号:32 (3): 587-599 被引量:7
标识
DOI:10.1185/03007995.2015.1136603
摘要

OBJECTIVE: This pooled, post hoc analysis evaluated the efficacy of desvenlafaxine vs placebo in adults with major depressive disorder (MDD) with and without metabolic syndrome, and above or at or below median baseline thyroid-stimulating hormone (TSH) levels. RESEARCH DESIGN AND METHODS: Patients were randomly assigned to receive desvenlafaxine 50 or 100 mg/d or placebo in nine short-term, double-blind studies. Metabolic syndrome was defined as meeting at least three of five criteria based on body mass index, triglycerides, high-density lipoprotein, fasting glucose, blood pressure, current medication, and medical history. CLINICAL TRIAL REGISTRATION: NCT00072774; NCT00277823; NCT00300378; NCT00384033; NCT00798707; NCT00863798; NCT01121484; NCT00824291; NCT01432457. MAIN OUTCOME MEASURES: Treatment effects on change from baseline in 17-item Hamilton Rating Scale for Depression (HAM-D17) total score at week 8 (last observation carried forward [LOCF]) were analyzed in four subgroups-metabolic syndrome and no metabolic syndrome, baseline TSH levels above median or at or below median-using analysis of covariance with treatment, study, and baseline in the model. Metabolic syndrome and TSH were examined as predictors of change in HAM-D17 total score using regression analysis. RESULTS: The pooled analysis included 4279 patients; 971 (22.7%) patients had metabolic syndrome. In all subgroups, HAM-D17 total scores improved significantly from baseline to week 8 (LOCF) with desvenlafaxine 50 or 100 mg/d compared with placebo (all p ≤ 0.006). There was no significant treatment by metabolic syndrome or by TSH interaction. Neither metabolic syndrome nor TSH above median predicted change in HAM-D17 total scores, response (≥50% reduction in HAM-D17 total score), or remission (HAM-D17 total score ≤7; all p > 0.05). LIMITATIONS: Individual studies included in this analysis were not designed to examine the relationship between metabolic syndrome or TSH and response to desvenlafaxine treatment. Metabolic syndrome status was determined post hoc based on available baseline measures and not diagnosed at study entry. Exclusion criteria were selected to enroll medically healthy patients with a primary diagnosis of MDD (i.e., patients healthier than the general MDD population). CONCLUSIONS: Desvenlafaxine 50 and 100 mg/d significantly improved depression compared with placebo in patients with and without metabolic syndrome, and in patients with baseline TSH above median and at or below median levels.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
小陈发布了新的文献求助10
2秒前
自由的觅松完成签到,获得积分10
2秒前
2秒前
2秒前
2秒前
超级的一鸣完成签到,获得积分10
2秒前
WYL发布了新的文献求助10
4秒前
zcs完成签到 ,获得积分10
4秒前
在水一方的应助被邻居家的猫采纳,获得10
4秒前
corleeang发布了新的文献求助10
5秒前
奥特曼完成签到,获得积分10
5秒前
又又完成签到,获得积分10
5秒前
xixidong发布了新的文献求助10
5秒前
5秒前
5秒前
6秒前
6秒前
星辰大海的应助被Firsterchao采纳,获得30
6秒前
故梦完成签到,获得积分20
6秒前
6秒前
dadada完成签到 ,获得积分10
7秒前
c29发布了新的文献求助10
7秒前
大与小房完成签到,获得积分10
8秒前
等待的含灵完成签到 ,获得积分10
8秒前
今后的应助被朱朱采纳,获得10
9秒前
9秒前
漫漫发布了新的文献求助10
9秒前
sttise完成签到 ,获得积分10
9秒前
run发布了新的文献求助10
9秒前
10秒前
11秒前
11秒前
11秒前
77发布了新的文献求助10
11秒前
木子姗完成签到,获得积分10
11秒前
精明怜南发布了新的文献求助30
12秒前
Sean完成签到,获得积分10
12秒前
TAOS完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182102
求助须知:如何正确求助?哪些是违规求助? 9571775
关于积分的说明 21819723
捐赠科研通 7778500
什么是DOI,文献DOI怎么找? 3433617
关于科研通互助平台的介绍 2557786
邀请新用户注册赠送积分活动 2479651